These results were for us a clear suggestion that CD4+ T cells were key in triggering a protective MHC class II-restricted anti-tumor immune response, because parental tumor cells were not capable to induce a similar protective CD4 or CD8 immune response. The gene discussed is HLA-C; the disease is neoplasm.